Smart medication management service based on additive manufacturing for elderly patients - (SmartDose)

age - uk发现，200万65岁以上的人每天至少服用7种处方药。随着人们年龄的增长，服用处方药的数量也在增加。持续管理和使用药物对于慢性疾病和疾病的成功康复或持续管理非常重要。该项目将开发SmartDose，这是一种集成解决方案，允许医生为患者开定制药物，允许药房生产这种药物，并且患者可以方便地在智能药丸分配器设备中收集和服用这种药物。SmartDose将使用3D药物打印机打印定制药物，医生根据个体患者的需要指定形状、颜色、大小和剂量。该联盟由一家专业生物技术公司FabRx领导，专注于开发用于制造药品和医疗设备的3D打印技术。伦敦布鲁内尔大学（BUL）也加入了他们的行列，他们开发了超声波和成像技术，可以改善打印过程。我们的尤里卡合作伙伴Yongatek是一家研发公司，已经为医疗保健领域开发了产品，并将开发原型系统。

Age-UK found that 2 million people over the age of 65 are taking at least seven prescribed medicines per day. The number of prescribed medications taken increases as people age. Consistent managing and consumption of medications is important for successful recovery or continued management of a chronic illness and disease.This project will develop SmartDose, an integrated solution that allows doctors to prescribe custom medication to patients, allows pharmacies to manufacture this medication and patients to conveniently collect and take this medication in a smart pill dispenser device. SmartDose will use a 3D pharmaceutical printer to print the custom medication, with the doctor specifying the shapes, colours, sizes, and doses based on an individual patient's need.The consortium is led by FabRx, a specialist biotech company, focused on developing 3D printing technology for fabricating pharmaceuticals and medical devices. They are joined by Brunel University London (BUL), who have developed ultrasonic and imaging technology that can improve the printing process. Our Eureka partner, Yongatek, are a research and development company who have developed products for the healthcare sector and will develop the prototype system.